Codexis/$CDXS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Codexis
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Ticker
$CDXS
Sector
Primary listing
Employees
146
Headquarters
Website
Codexis Metrics
BasicAdvanced
$243m
-
-$0.50
2.50
-
Price and volume
Market cap
$243m
Beta
2.5
52-week high
$3.87
52-week low
$0.96
Average daily volume
1.4m
Financial strength
Current ratio
3.824
Quick ratio
3.511
Long term debt to equity
139.057
Total debt to equity
144.883
Interest coverage (TTM)
-8.49%
Profitability
EBITDA (TTM)
-33.084
Gross margin (TTM)
12.42%
Net profit margin (TTM)
-62.47%
Operating margin (TTM)
-54.46%
Effective tax rate (TTM)
-0.11%
Revenue per employee (TTM)
$480,000
Management effectiveness
Return on assets (TTM)
-16.14%
Return on equity (TTM)
-74.88%
Valuation
Price to revenue (TTM)
3.306
Price to book
4.78
Price to tangible book (TTM)
5.03
Price to free cash flow (TTM)
-9.757
Free cash flow yield (TTM)
-10.25%
Free cash flow per share (TTM)
-0.274
Growth
Revenue change (TTM)
18.61%
Earnings per share change (TTM)
-43.25%
3-year revenue growth (CAGR)
-20.22%
10-year revenue growth (CAGR)
5.35%
3-year earnings per share growth (CAGR)
-0.62%
10-year earnings per share growth (CAGR)
10.13%
What the Analysts think about Codexis
Analyst ratings (Buy, Hold, Sell) for Codexis stock.
Codexis Financial Performance
Revenues and expenses
Codexis Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Codexis stock?
Codexis (CDXS) has a market cap of $243M as of May 04, 2026.
What is the P/E ratio for Codexis stock?
The price to earnings (P/E) ratio for Codexis (CDXS) stock is 0 as of May 04, 2026.
Does Codexis stock pay dividends?
No, Codexis (CDXS) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Codexis dividend payment date?
Codexis (CDXS) stock does not pay dividends to its shareholders.
What is the beta indicator for Codexis?
Codexis (CDXS) has a beta rating of 2.5. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.